Additionally, lipid−saporin NPs were utilised to bypass efflux transporters via co-delivery of anticancer drugs with ABC transporters, which led to an increase in intracellular drug concentrations and re-sensitisation of drug-resistant cancer cells to chemotherapy [210]. Here, ABCG2 is linked to cancer.